Peter Lynch

Research in Motion: Vulnerable to a Takeover Bid?

RIMM is still over-valued at the current price. And in the current market, no company in any sector is willing to do a big M&A deal in this environment. Walgreen just withdrew its offer for Long drugs, and it was for less than $3 billion.

Sell your RIMM at the next uptick.